ZRANB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.09119968405969E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.960400E-04 |
Normal-vs-Stage2 |
3.5211000000035E-05 |
Normal-vs-Stage3 |
8.68416449861797E-13 |
Normal-vs-Stage4 |
5.79458703242608E-12 |
Stage1-vs-Stage2 |
3.347900E-02 |
Stage1-vs-Stage3 |
1.94039999956708E-07 |
Stage1-vs-Stage4 |
1.37089999996398E-06 |
Stage2-vs-Stage3 |
1.848430E-01 |
Stage2-vs-Stage4 |
1.011000E-01 |
Stage3-vs-Stage4 |
5.094800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.48209999828453E-10 |
Normal-vs-AfricanAmerican |
1.167520E-02 |
Normal-vs-Asian |
8.317700E-02 |
Caucasian-vs-AfricanAmerican |
1.096220E-01 |
Caucasian-vs-Asian |
6.180200E-01 |
AfricanAmerican-vs-Asian |
9.026800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.75020006768045E-11 |
Normal-vs-Female |
1.9950799999946E-05 |
Male-vs-Female |
1.024020E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.301500E-02 |
Normal-vs-Age(41-60Yrs) |
1.24359999997825E-06 |
Normal-vs-Age(61-80Yrs) |
6.88630263923073E-11 |
Normal-vs-Age(81-100Yrs) |
4.12530000049038E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.808600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.369600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.696020E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.110300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.119600E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.978050E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.980800E-01 |
Normal-vs-Grade 2 |
8.789200E-04 |
Normal-vs-Grade 3 |
4.33053592985289E-12 |
Normal-vs-Grade 4 |
1.34114941374719E-13 |
Grade 1-vs-Grade 2 |
4.922300E-02 |
Grade 1-vs-Grade 3 |
3.91640000000359E-05 |
Grade 1-vs-Grade 4 |
3.43169999994508E-06 |
Grade 2-vs-Grade 3 |
3.75299999966217E-07 |
Grade 2-vs-Grade 4 |
5.54929999729836E-08 |
Grade 3-vs-Grade 4 |
2.643700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.120600E-03 |
Normal-vs-ccB subtype |
3.93618471150603E-12 |
ccA subtype-vs-ccB subtype |
3.13659999973126E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.00940000381212E-09 |
Normal-vs-N1 |
2.27190000146038E-08 |
N0-vs-N1 |
2.648300E-02 |
|
|